These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22723667)

  • 1. Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour.
    Kubota D; Okubo T; Saito T; Suehara Y; Yoshida A; Kikuta K; Tsuda H; Katai H; Shimada Y; Kaneko K; Kawai A; Kondo T
    Jpn J Clin Oncol; 2012 Aug; 42(8):730-41. PubMed ID: 22723667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities.
    Kubota D; Orita H; Yoshida A; Gotoh M; Kanda T; Tsuda H; Hasegawa T; Katai H; Shimada Y; Kaneko K; Kawai A; Kondo T
    Jpn J Clin Oncol; 2011 Oct; 41(10):1194-202. PubMed ID: 21903705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody.
    Kubota D; Mukaihara K; Yoshida A; Suehara Y; Saito T; Okubo T; Gotoh M; Orita H; Tsuda H; Kaneko K; Kawai A; Kondo T; Sato K; Yao T
    Jpn J Clin Oncol; 2013 Jun; 43(6):669-75. PubMed ID: 23619989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
    Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
    Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities.
    Kikuta K; Gotoh M; Kanda T; Tochigi N; Shimoda T; Hasegawa T; Katai H; Shimada Y; Suehara Y; Kawai A; Hirohashi S; Kondo T
    Jpn J Clin Oncol; 2010 Jan; 40(1):60-72. PubMed ID: 19815537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor.
    Kikuta K; Kubota D; Saito T; Orita H; Yoshida A; Tsuda H; Suehara Y; Katai H; Shimada Y; Toyama Y; Sato K; Yao T; Kaneko K; Beppu Y; Murakami Y; Kawai A; Kondo T
    J Proteomics; 2012 Feb; 75(4):1089-98. PubMed ID: 22119546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarker development by cancer proteomics].
    Kondo T
    Nihon Rinsho; 2012 May; 70(5):754-8. PubMed ID: 22619997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
    Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
    Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
    Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors.
    Orita H; Ito T; Kushida T; Sakurada M; Maekawa H; Wada R; Suehara Y; Kubota D; Sato K
    Biomed Res Int; 2014; 2014():651935. PubMed ID: 24977158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosis.
    Haller F; Agaimy A; Cameron S; Beyer M; Gunawan B; Happel N; Langer C; Ramadori G; von Heydebreck A; Füzesi L
    Histopathology; 2010 Feb; 56(3):305-18. PubMed ID: 20459531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
    Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
    Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in gastrointestinal stromal tumors among a group of Mexican patients].
    Medina-Franco H; Aguilar-Jiménez JR; Medina-Cuairán JZ
    Gac Med Mex; 2009; 145(2):91-6. PubMed ID: 19518014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.
    Schneider-Stock R; Boltze C; Lasota J; Peters B; Corless CL; Ruemmele P; Terracciano L; Pross M; Insabato L; Di Vizio D; Iesalnieks I; Dirnhofer S; Hartmann A; Heinrich M; Miettinen M; Roessner A; Tornillo L
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):638-45. PubMed ID: 15701851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
    Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
    Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.